Paracelsian other research news

The Ithaca, N.Y., company announced that it is testing several inhibitors of protein tyrosine kinase, an intracellular signaling pathway for T cell activation. PRLN said earlier research had associated enhanced activation of cyclin-dependent kinases with T cell destruction attributed to HIV.

One agent, PN355, inhibits replication of HIV in vitro. It also induces cell death in HIV-infected cells. ...